MENU

AGLE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Aeglea BioTherapeutics (AGLE) Ownership - Who owns Aeglea BioTherapeutics?

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

805 Las Cimas Parkway

Phone

+1 512 942-2935

Employees

69

Web

https://www.aegleabio.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

44.7M

P/E Ratio

N/A

Total Cash

203.6M

Projected Growth

N/A

Total Debt

N/A

Revenue

1.05M

Risk (Beta)

3.03

Dividend Yield

N/A

Total Cash/Share

50.28

Total Debt/Equity

N/A

Revenue/Share

0.27 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AGLE

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details

Industry

N/A

Address

805 Las Cimas Parkway

Phone

+1 512 942-2935

Employees

69

Web

https://www.aegleabio.com